Cite
RAS pathway influences the number of melanocytic nevi in cardiofaciocutaneous and Costello syndromes.
MLA
Kiuru, Maija, et al. “RAS Pathway Influences the Number of Melanocytic Nevi in Cardiofaciocutaneous and Costello Syndromes.” Journal of the American Academy of Dermatology, vol. 82, no. 5, May 2020, pp. 1091–93. EBSCOhost, https://doi.org/10.1016/j.jaad.2020.01.038.
APA
Kiuru, M., Urban, J., Zhu, G., Rybak, I., Terrell, J. R., Qi, L., McPherson, J. D., Marghoob, A. A., & Rauen, K. A. (2020). RAS pathway influences the number of melanocytic nevi in cardiofaciocutaneous and Costello syndromes. Journal of the American Academy of Dermatology, 82(5), 1091–1093. https://doi.org/10.1016/j.jaad.2020.01.038
Chicago
Kiuru, Maija, Jennifer Urban, Guannan Zhu, Iryna Rybak, Jessica R Terrell, Lihong Qi, John D McPherson, Ashfaq A Marghoob, and Katherine A Rauen. 2020. “RAS Pathway Influences the Number of Melanocytic Nevi in Cardiofaciocutaneous and Costello Syndromes.” Journal of the American Academy of Dermatology 82 (5): 1091–93. doi:10.1016/j.jaad.2020.01.038.